Login to Your Account



Financings Roundup


Wednesday, February 9, 2011
EpiCept Corp., of Tarrytown, N.Y., said it expects to receive about $6.6 million in net proceeds from an offering of about 8.9 million shares of common stock at 80 cents per share and five-year warrants for as many as 3.6 million shares of common stock at 75 cents per share. Rodman & Renshaw LLC acted as exclusive placement agent. Net proceeds from the offering will be used for working capital and general corporate purposes. The offering is expected to close by Feb. 10.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription